Adverse metabolic consequences of androgen deprivation therapy (ADT) on Asian patients with prostate cancer: Primary results from the real-life experience of ADT in Asia (READT) study.
Chris H M WongNing XuJasmine LimKuo-Kang FengWayne K W ChanMarco T Y ChanSteven Chi Ho LeungDong-Ning ChenYun-Zhi LinPeter K F ChiuChi Hang YeeJeremy Y C TeohChiu-Yuen HuangWei-Sien YeohTeng-Aik OngYong WeiChi-Fai NgPublished in: The Prostate (2023)
ADT was associated with adverse metabolic parameters in terms of glycemic profiles, lipid profiles, and body weight in the Asian population. These changes developed early in the treatment and can persist beyond the first year. Regular monitoring of the biochemical profiles during treatment is paramount in safeguarding the patients' metabolic health.
Keyphrases
- body weight
- prostate cancer
- end stage renal disease
- ejection fraction
- newly diagnosed
- healthcare
- public health
- type diabetes
- mental health
- radical prostatectomy
- prognostic factors
- peritoneal dialysis
- emergency department
- stem cells
- health information
- patient reported outcomes
- metabolic syndrome
- adipose tissue
- bone marrow
- glycemic control